Melanotan II Results Timeline
What the standard Melanotan II research protocol looks like phase by phase, over a typical 4–8 weeks loading; ongoing maintenance cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Compare:PT-141 vs Melanotan II →
Quick Facts
FREQUENCYOnce daily (loading) → 2–3× weekly (maintenance)
CYCLE LENGTH4–8 weeks loading; ongoing maintenance
DOSE RANGE250–1,000 mcg
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Loading Weeks 1–2
Target dose: 250 mcg daily
Escalation
Loading Weeks 3–4
Target dose: 500 mcg daily
Maintenance
Maintenance
Target dose: 500–1,000 mcg 2–3×/week
Reported in Research
- ✓Daily during loading phase (4–8 weeks), then 2–3 times weekly for maintenance.
- ✓Loading: 4–8 weeks daily.
This timeline reflects the structure of the standard Melanotan II research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.